DiaMedica Therapeutics (DMAC) EPS (Basic) (2018 - 2019)
Historic EPS (Basic) for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to -$0.21.
- DiaMedica Therapeutics' EPS (Basic) rose 1711.83% to -$0.21 in Q4 2019 from the same period last year, while for Dec 2019 it was -$0.89, marking a year-over-year decrease of 2019.07%. This contributed to the annual value of -$0.6 for FY2024, which is 0.0% changed from last year.
- Latest data reveals that DiaMedica Therapeutics reported EPS (Basic) of -$0.21 as of Q4 2019, which was up 1711.83% from -$0.2 recorded in Q3 2019.
- DiaMedica Therapeutics' 5-year EPS (Basic) high stood at -$0.1 for Q1 2018, and its period low was -$0.27 during Q1 2019.